Kraig Biocraft Laboratories Accelerates Operations into Two Rearing Centers in One of Southeast Asia's Premier Silk-Producing Regions
Rhea-AI Summary
Kraig Biocraft Laboratories (OTCQB: KBLB), a leader in spider silk technology, has announced the successful transition of its production operations to two new rearing centers in a major Southeast Asian silk-producing region. The new facilities, operated by the Company's subsidiary Prodigy Silk, have already surpassed all previous years of production combined since the first center opened in early 2024.
The modern rearing centers combine advanced biotechnology with the region's established sericulture expertise, favorable climate, and infrastructure. The Company is completing the transfer of equipment from its original pilot facility, with completion expected by the end of August 2025. This strategic move represents a significant expansion milestone for Kraig Labs in commercializing spider silk technology.
Positive
- Production output since early 2024 exceeds all previous years combined
- Strategic location in one of Asia's premier silk-producing regions provides natural advantages
- Modern facilities combine advanced biotechnology with regional expertise
- Successful consolidation of operations into purpose-built commercial facilities
Negative
- Complete dependence on new regional facilities may present geographic concentration risk
News Market Reaction
On the day this news was published, KBLB declined 0.13%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
ANN ARBOR, Mich., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that its two recently established rearing centers, located in the heart of one of Asia's leading silk-producing regions, have now completely replaced the Company's original Prodigy Textiles pilot facility as the center of production.
Since opening the first of these two new rearing centers in early 2024, Kraig Labs has produced more recombinant spider silk than in all previous years of the Company's operations combined. These modern rearing centers provide an optimized production environment, combining advanced biotechnology with the region's unmatched sericulture expertise, favorable climate, and established infrastructure.
Kraig Labs has already begun transferring equipment from its original pilot facility to the new commercial production centers, with the process expected to be completed by the end of August. The commercial production facilities will now be operated by the Company’s wholly owned subsidiary, Prodigy Silk. The Prodigy Textile brand will remain active as a DBA of Kraig Labs.
"This marks a major milestone for Kraig Labs," said Jon Rice, COO of Kraig Labs. "By moving all of our resources into these purpose-built rearing centers, we are achieving a key expansion objective for 2025, operating in one of the world's leading silk production locations. With the region's natural advantages and our cutting-edge science, we are creating the strongest platform yet to deliver the promise of recombinant spider silk to global markets."
The establishment of these rearing centers is the culmination of nearly a decade of planning. With operations now anchored in one of the world's foremost silk-producing regions, Kraig Labs is taking a significant step forward in its mission to commercialize spider silk.
For the latest updates on Kraig Labs and its pioneering spider silk technologies, visit www.kraiglabs.com.
For details about other recent Kraig Labs advancements, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
To view the most recent news from Kraig Labs and/or to sign up for Company alerts, please go to www.KraigLabs.com/news
* For a description of our historical leadership in this technology, please follow this link https://www.kraiglabs.com/world-leader/
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are "forward-looking statements." These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as "believes," "plans," "expects," "anticipates," "foresees," "estimated," "hopes," "if," "develops," "researching," "research," "pilot," "potential," "could" or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, Inc.
(720) 288-8495
ir@KraigLabs.com
FAQ
What are the new developments at Kraig Biocraft Laboratories (KBLB) in 2025?
Where are KBLB's new production facilities located?
How will the new rearing centers impact KBLB's production capacity?
Who will operate KBLB's new production facilities?
When will KBLB complete the transition to the new facilities?
